What the research shows
- Selank: matched medazepam in anxiety trial
- Semax: raised BDNF in stroke-rehab trial
- Semax: used clinically for mental fatigue
Published study results for the compound, not results from this product. For research use only.
This equal-mass 3mL pen combines Selank, a tuftsin-derived heptapeptide, with Semax, an ACTH(4-7)-Pro-Gly-Pro heptapeptide. The compounds have separate preclinical research histories, and no evidence for a distinct fixed-combination effect is supplied. No batch-specific independent report is linked, so sequence, component identity, quantity and purity are unverified.
- Pack Size
- 3mL
- Product details
- Genovare Catalogue
- Pre-Filled Pen
- Premixed Aqueous
- Storage Guidance
- Follow Package Label
- 1 pre-filled Genovare research pen
- 3 pen needles
- Genovare retail packaging
Genovare Pre-Filled Pen Premixed Aqueous
SpecsSelank + Semax 50mg Total (25mg + 25mg) AQ Pen
Pairs anxiolytic Selank with nootropic Semax
AED 1,100 / pen
Choose your bundle
Minimum order is AED 400
25% off orders of AED 700+ with code KV25 at checkout
Order before 4 PM for same-day Dubai delivery.
UAE delivery: AED 50 below AED 1,000; free from AED 1,000
- Sold by
- Remy Research
- Brand
- Genovare
- Manufacturer
- Genovare
- Tested by
- Independent testing not supplied
Ships from Dubai
Technical Specifications
| Manufacturer | Genovare |
|---|---|
| Compound | Selank + Semax |
| Catalogue strength | 50 mg total (25 mg + 25 mg) |
| Fill volume | 3mL |
| Format | Aqueous pre-filled pen |
| Pack size | 1 pen with 3 needles |
| Independent testing | Not supplied |